Ipca Laboratories regular Real Value cannot be determined due to lack of data. The prevalent price of Ipca Laboratories is 732.75. Based on Macroaxis valuation methodology, the corporation cannot be evaluated at this time. Macroaxis calculates value of Ipca Laboratories from evaluating the corporation fundamentals such as Current Valuation of 102.47B, Return On Asset of
4.31% and Return On Equity of 9.31% as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage to acquire undervalued assets and to sell overvalued assets since at some point stocks prices and their ongoing real values will come together.
|Horizon||30 Days Login to change|
Ipca Laboratories Limited is rated below average in last dividend paid category among related companies. It is currently regarded as number one stock in five year return category among related companies reporting about 3.48 of Five Year Return per Last Dividend Paid.
|Last Dividend Paid|
|Five Year Return ( % )|
Ipca Laboratories is Unknown risk asset. Calculation of real value of Ipca Laboratories is based on 2 months time horizon. Increasing Ipca Laboratories time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.